Almond

Almond (Prunus dulcis)

Identity and Botanical Classification

Almond is formally designated Prunus dulcis (Mill.) D.A. Webb, with accepted synonyms including Prunus amygdalus Batsch, Amygdalus communis L., and Amygdalus dulcis Mill. It is a deciduous tree belonging to the family Rosaceae, subfamily Prunoideae, and represents one of the earliest domesticated nut trees, with an ancient history spanning over three millennia.

Although commonly referred to as a "nut," the almond is botanically categorized as a drupe of the Rosaceae family and the sub-genus Amygdalus. Indigenous to Central and Western Asia — particularly the arid mountainous regions ranging from Central Asia through Afghanistan, Iran, and Iraq — almond cultivation has expanded globally to encompass Mediterranean countries, California, China, Greece, Kashmir, and Punjab, making it one of the most economically significant nut crops worldwide.

Almonds (Prunus dulcis) are one of the most consumed tree nuts worldwide, with commercial production in arid environments such as California, Spain, and Australia. Production has increased significantly in the past two decades, with 3.12 billion pounds of kernel meat produced in California alone in 2020, leading to a new emphasis on the valorization of coproducts such as hulls, shells, skins, and blanch water.

Sweet vs. Bitter Varieties

A fundamental distinction exists between two principal varieties of almond. Almond is the principal Prunus species in which the consumed and commercially important part of the fruit is the kernel. As a result of continued selection, the vast majority of almonds have a nonbitter kernel. However, trees carrying bitter kernels also exist in the field, which are toxic to humans and consequently need to be removed. The toxicity of bitter almonds is caused by the accumulation of the cyanogenic diglucoside amygdalin, which releases toxic hydrogen cyanide upon hydrolysis.

Common Forms and Preparations

The high consumption of almonds is partly due to their versatile usage in products such as gluten-free flour and dairy alternatives, as well as their role as a source of protein in vegetarian diets. Commercially, almonds are available in a broad range of forms: whole raw kernels, dry-roasted or oil-roasted kernels, blanched (skin-removed) kernels, slivered or sliced preparations, almond flour, almond butter, almond oil, and almond milk. The skin (testa) of the kernel, which remains after blanching or is mechanically separated, is increasingly recognized as a separate bioactive fraction in research contexts due to its concentrated polyphenol content.

Traditional and Historical Use

Ancient Origins and Archaeological Record

Domesticated almonds first appeared in the Early Bronze Age (3000–2000 B.C.E.) in the Near East, or possibly a little earlier at the dawn of agriculture. A well-known archaeological example of the almond is fruit found in Tutankhamun's tomb in Egypt (c. 1325 B.C.E.) and at Deir el-Medina, which was probably imported from the Levant. Ancient Egyptians, Greeks, and Romans spread almonds throughout the Mediterranean and into northern Africa and southern Europe.

Ayurvedic Tradition

As the most widely cultivated nut tree in the world, almonds have been revered across ancient cultures for their unique ability to build strength, sharpen intelligence, and nourish the body deeply. Originally native to the Levant region and extending across northern Africa, almonds hold a distinguished place in Greek, Unani, and Ayurvedic medicine traditions.

In Ayurvedic texts, almonds, known as Badam, are highly revered for their sweet and slightly warming nature. They are often recommended to nourish ojas — the body's vital life sap that governs immunity, vitality, and overall vigor. Almonds are classified as both a food and a healing substance. In Ayurvedic nutrition, almonds are mentioned as both a daily dietary addition and a therapeutic remedy; ancient physicians recommended them to people suffering from wasting diseases, respiratory troubles, and skin conditions.

Traditional Chinese Medicine

Under the guidance of Traditional Chinese Medicine (TCM) theory, bitter almonds should be processed before being used as medicine. The change in properties of Chinese Materia Medica is a core tenet of the processing principle. The processing principle of bitter almonds in TCM is shameibaogan, which means inhibiting enzymes and preserving the amygdalin in the bitter almonds. Scalded and stir-fried bitter almond preparations are common clinical drugs in TCM; the efficacy of relieving cough and asthma is enhanced in processed products, and in scalded products the toxicity of bitter almonds is reduced, whereas stir-fried products are considered more suitable for treating long-term cough with asthma.

Mediterranean and Middle Eastern Traditions

Ethnobotanical investigations across Asia, Mediterranean, and Middle Eastern regions documented traditional applications for neurological disorders, including memory loss and insomnia, among other conditions. Almond oil — expressed from both sweet and bitter kernels — was historically applied topically for skin emollience and cosmetic uses across multiple cultures throughout the Mediterranean basin.

Key Constituents and Active Compounds

Macronutrient Profile

Almonds demonstrate exceptional nutritional density, with 31.55% monounsaturated fatty acids, 21.2 g/100 g protein, 12% dietary fiber, and abundant vitamin E and minerals. They are devoid of cholesterol and saturated fatty acids but are packed with all essential amino acids, omega-3 fatty acids, and essential phenolics. European regulation has categorized almonds as a high-fiber food.

Polyphenols

The almond tree (Prunus dulcis) is a rich reservoir of diverse phytochemical compounds distributed across its various botanical parts, including kernels, skins, shells, hulls, leaves, and bark. These bioactive constituents contribute significantly to the nutritional and therapeutic properties of almonds, encompassing several chemical classes such as polyphenols, terpenoids, fatty acids, vitamins, and minerals.

Phytochemical profiling has revealed diverse bioactive compounds including polyphenols (flavonoids, procyanidins, ellagitannins), terpenoids (ursolic acid, betulinic acid), and phytosterols. While almonds are an excellent source of the antioxidant vitamin E, the polyphenols in almond skins may also contribute to their antioxidant capacity and health-promoting actions. The almond skin, which constitutes only a small fraction of kernel weight, contains highly concentrated polyphenolic compounds including flavonoids and proanthocyanidins.

Terpenoids and Phytosterols

The terpenoid fraction of almond exhibits significant biological potential, with ursolic acid, betulinic acid, and oleanolic acid being the principal triterpenoids identified in hull tissues, collectively constituting approximately 1% of hull dry weight. The sterol composition includes β-sitosterol, stigmasterol, campesterol, and 5-avenasterol, with β-sitosterol representing the dominant phytosterol across almond fractions. These compounds contribute to the cholesterol-lowering properties associated with almond consumption.

Vitamin E (Alpha-Tocopherol)

Almonds provide approximately 12.5 mg vitamin E (alpha-tocopherol) per 50.0 g serving. Vitamin E is a fat-soluble vitamin with strong antioxidant properties that is incorporated into cell membranes and effectively protects against free radical damage caused by intrinsic and exogenous stressors, including ultraviolet radiation. When ingested, dietary alpha-tocopherol can increase skin concentrations of vitamin E.

Amygdalin and Cyanogenic Glycosides

Amygdalin (d-Mandelonitrile 6-O-β-d-glucosido-β-d-glucoside) is a natural cyanogenic glycoside occurring in the seeds of some edible plants, such as bitter almonds and peaches. It is a medically interesting but controversial compound, as it has potential anticancer activity on one hand and can be toxic via enzymatic degradation and production of hydrogen cyanide on the other.

HCN levels in bitter almond (1062 ± 148.70 mg/kg) are approximately 40 times higher than levels found in sweet almond (25.20 ± 8.24 mg/kg). Almonds are the least allergenic tree nut and contain minute quantities of cyanogenic glycosides.

Fatty Acid Composition and Fiber

The predominant fatty acid in sweet almond kernels is oleic acid (a monounsaturated omega-9 fatty acid), followed by linoleic acid (an omega-6 polyunsaturated fatty acid). Almonds are rich in nutrients — high in fiber, protein, and healthy fats — which collectively enhance satiety and decrease overall caloric intake. The dietary fiber component consists of both soluble and insoluble fractions; the insoluble component of the cell wall contributes to the incomplete absorption of fat from almonds, a mechanism relevant to their effects on body weight and metabolizable energy.

Mechanisms of Action

Lipid Modulation

The cholesterol-lowering effects of almonds are attributed to multiple converging mechanisms. Oleic acid — the predominant monounsaturated fatty acid — replaces dietary saturated fat and reduces the hepatic synthesis of LDL particles. Phytosterols, particularly β-sitosterol, competitively inhibit intestinal absorption of dietary cholesterol by displacing it from mixed micelles in the gut lumen. Almonds are rich in monounsaturated fats, fiber, vitamins, minerals, and polyphenols, which contribute to their health-promoting properties. Regular intake of almonds has been shown to improve lipid profiles by reducing LDL cholesterol and enhancing HDL functionality.

Antioxidant Defense

Observational studies and clinical trials suggest nut intake, including almonds, is associated with an enhancement in antioxidant defense and a reduction in the risk of cancer and cardiovascular disease. Almond skins are rich in polyphenols (ASP) that may contribute to these putative benefits. In vitro testing has assessed the effect of ASP extracted with methanol or a gastrointestinal juice mimic on scavenging free radicals and inducing quinone reductase (QR). In a placebo-controlled, three-way crossover trial, consumption of almond skin polyphenols increased the polyphenols catechin and naringenin, the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG), and the activity of the antioxidant enzyme glutathione peroxidase (GPx) in plasma.

Glycemic Regulation

Almonds can decrease the glycemic index of co-consumed foods and are a rich source of oleic acid and alpha-tocopherol. Almonds are a low-glycemic index food, with high fiber, unsaturated fat, and low carbohydrate content. The viscous fiber and lipid matrix of almonds slow gastric emptying and glucose absorption, while the lipid component suppresses postprandial insulin secretion. Incomplete fat absorption from the intact cell wall matrix further reduces net caloric availability.

Gut Microbiome Modulation

Nuts such as almonds are rich sources of fiber, unsaturated fats, and polyphenols — all nutrients that can favorably alter the gut microbiome. Almond consumption appears to modulate the gut microbiome by promoting the growth of beneficial bacteria and increasing short-chain fatty acid (SCFA) production, particularly butyrate. These effects collectively contribute to the anti-inflammatory and cardioprotective benefits of almonds.

Satiety and Energy Metabolism

The biological mechanisms for almond weight control include enhanced displacement of other foods, decreased macronutrient bioavailability for a lower net metabolizable energy (ME), upregulation of acute signals for reduced hunger, elevated satiety, and increased resting energy expenditure. The high fiber content of almonds can decrease the bioavailability of macronutrients, thereby reducing net metabolizable energy.

Scientific Evidence by Area of Use

Cardiovascular Health

Evidence level: Strong (multiple RCTs and meta-analyses).

A meta-analysis of fifteen eligible randomized controlled trials analyzing a total of 534 subjects found that almond intervention significantly decreased total cholesterol (summary net change: −10.69 mg/dL; 95% CI: −16.75, −4.63 mg/dL), LDL cholesterol (summary net change: −5.83 mg/dL; 95% CI: −9.91, −1.75 mg/dL), body weight (summary net change: −1.39 kg; 95% CI: −2.49, −0.30 kg), HDL cholesterol (summary net change: −1.26 mg/dL; 95% CI: −2.47, −0.05 mg/dL), and apolipoprotein B (apoB) (summary net change: −6.67 mg/dL; 95% CI: −12.63, −0.72 mg/dL). Triglycerides, systolic blood pressure, apolipoprotein A1, high-sensitivity C-reactive protein, and lipoprotein(a) showed no significant difference between almond and control groups.

The intake of 42.5 g/day of almonds significantly lowered LDL cholesterol, 10-year Framingham estimated coronary heart disease risk, and associated cardiovascular disease medical expenditures. Diastolic blood pressure was modestly but significantly lowered when almonds were consumed at greater than 42.5 g/day or for more than 6 weeks.

A randomized controlled trial (the ATTIS study) demonstrated that whole almonds consumed as snacks markedly improve endothelial function, in addition to lowering LDL cholesterol, in adults with above-average risk of CVD.

Consumption of almond skin polyphenols has also been shown to inhibit LDL oxidation, which is an important etiological factor for cardiovascular diseases.

In epidemiological studies, the consumption of almonds has been associated with several therapeutic and protective health benefits. Clinical studies have verified the modulatory effects on serum glucose, lipid and uric acid levels, the regulatory role on body weight, and protective effects against diabetes, obesity, metabolic syndrome, and cardiovascular diseases.

Glycemic Control and Diabetes Risk

Evidence level: Moderate to good (multiple RCTs, though results are heterogeneous).

Research has found that the incorporation of almonds into a healthy dietary plan might help improve long-term glycemic status in patients with better glucose control.

A study hypothesized that dietary intervention of preloading major meals with almonds in participants with prediabetes would decrease overall glycemia and postprandial hyperglycemia (PPHG). The study included a phase evaluating the effect of a single premeal almond load of 20 g given before an oral glucose tolerance test (n = 60), and a continuous glucose monitoring system (CGMS)-based phase for 3 days with premeal almond load before three major meals as a free-living, open-labeled, crossover randomized controlled trial (n = 60 in each period).

Incorporation of 20 g of almonds 30 minutes before each major meal led to a significant decrease in postprandial hyperglycemia (as revealed in the OGTT-based study phase) and also improved insulin, C-peptide, and glucagon levels, and improved glucose variability and glycemic parameters on CGMS in participants with prediabetes.

A separate randomized controlled trial explored the effect of almond consumption on blood glucose, lipids, insulin, and selected inflammatory markers in adolescents and young adults aged 16–25 years. The trial was conducted on individuals with impaired fasting glucose levels between 100–125 mg/dL and 2-hour post-glucose value of 140–199 mg/dL, and/or fasting hyperinsulinemia. Of 1,313 individuals screened, 421 met inclusion criteria, and 219 completed the trial. The almonds group (n = 107) consumed 56 g almonds daily, while the control group (n = 112) was provided an isocaloric cereal-pulse based snack.

In a study of adults with impaired glucose tolerance, whole almonds significantly attenuated second-meal and daylong blood glucose incremental area under the curve (AUCI) and provided the greatest daylong feeling of fullness. The inclusion of almonds in the breakfast meal decreased blood glucose concentrations and increased satiety both acutely and after a second meal in adults with impaired glucose tolerance.

Limitations across this body of research include heterogeneity in participant populations (healthy vs. prediabetic vs. type 2 diabetic), variation in almond doses and intervention duration, and the challenge of isolating almond-specific effects within mixed dietary interventions.

Body Weight and Adiposity

Evidence level: Moderate (consistent direction, though effect sizes are modest).

A comprehensive narrative review of 64 randomized controlled trials (RCTs) and 14 systematic reviews and/or meta-analyses found that almonds are a higher energy-dense food that acts like a lower energy-dense food when consumed. Recent systematic reviews and meta-analyses of nut RCTs showed that almonds were the only nut that had a small but significant decrease in both mean body mass and fat mass, compared to control diets.

A global expert consensus confirms that almond consumption, even at doses ranging from 10–100 g/day for periods up to 18 months, does not lead to weight gain and may contribute to slight weight loss. This effect is attributed to almonds' lower metabolizable energy, incomplete fat absorption, and their role in promoting satiety, which may reduce overall caloric intake.

A 12-week clinical trial was carried out with 86 healthy subjects with a BMI ranging from 25 to 40 kg/m² who were randomized into two diet intervention groups: an almond-enriched hypocaloric diet (AED, 15% of total kcal from almonds) and a nut-free hypocaloric diet (NFD). Each diet provided a daily 500-kcal deficit. After the intervention period, although subjects in both groups lost body weight, those who followed the AED showed significantly higher reductions in total and truncal fat mass, as well as an increase in total and truncal fat-free mass (p < 0.05).

Gut Microbiome (Prebiotic Effects)

Evidence level: Preliminary but promising (small number of RCTs).

Recent researchers have confirmed the prebiotic potential of almonds. Eight RCTs show that almonds can support colonic microbiota health by promoting microflora richness and diversity, increasing the ratio of symbiotic to pathogenic microflora, and concentrations of health-promoting colonic bioactives.

Based on the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus, polyphenols that modulate the gut microbiota may now be considered as prebiotics. The ISAPP updated the definition of prebiotics in 2017 to "a substrate that is selectively utilized by host microorganisms conferring a health benefit." Almonds contain both dietary fiber and polyphenols — particularly from the skin — that may function via this expanded prebiotic mechanism.

Antioxidant Status and Oxidative Stress

Evidence level: Moderate (RCTs and in vitro data, mechanism reasonably established).

Almonds aid in glycemic control, blood pressure reduction, and chronic inflammation amelioration, which are critical for cardiovascular health. The antioxidant properties of almonds, primarily due to their high vitamin E content, help in reducing oxidative stress markers. Almond supplementation has been shown to enhance antioxidant defenses and reduce biomarkers of oxidative stress in smokers, and almond consumption decreased lipid peroxidation in hyperlipidemic men.

In vitro studies demonstrated that pretreatment with almond skin extract inhibited the formation of reactive oxygen species (ROS) and apoptosis. In vivo studies showed that almond skin extract restored tissue changes caused by carrageenan-induced inflammation; restored the activity of endogenous antioxidant enzymes such as superoxide dismutase, catalase, and glutathione; and decreased neutrophil infiltration, lipid peroxidation, and the release of proinflammatory mediators. These are primarily preclinical findings and should be interpreted accordingly.

Cognitive Performance

Evidence level: Preliminary and insufficient to draw firm conclusions.

Recent RCTs suggest possible emerging health benefits for almonds such as enhanced cognitive performance, improved heart rate variability under mental stress, and reduced rate of facial skin aging from exposure to ultraviolet (UV) B radiation.

In one trial, the 42 g almond group had a significant improvement in the Motor Screening Task — a general assessment of sensorimotor function and comprehension — at 3 months but not at 6 months. The 84 g almond group at 6 months showed significant improvements in visuospatial working memory (p = 0.023), in visual memory and learning (p = 0.017), and in spatial planning and working memory (p = 0.001). However, changes in any cognitive scores over time did not statistically differ among the three groups.

The independent effect of almonds on cognitive performance may be relatively small, and studies of longer duration, with a larger number of subjects and other control diets, are warranted to provide additional evidence of the beneficial effects of almonds on cognitive performance in middle-aged and older adults.

Skin Health

Evidence level: Preliminary (limited RCT data).

Almonds are a rich dietary source of a range of fatty acids, polyphenols, and other phytochemicals with antioxidant properties. The modulation of serum lipid profiles by almond supplementation has been studied in detail; conversely, effects on the skin's lipid barrier function are understudied, although alteration of the skin barrier can improve several skin features including wrinkles. Almond consumption may contribute to the photoaging defenses of the skin. This area of research is nascent, and findings from individual RCTs require replication in larger, longer trials before firm conclusions can be drawn.

Body Systems and Health Areas Associated with Almond

• Cardiovascular system: LDL and total cholesterol reduction, improvement of endothelial function, modest blood pressure reduction, inhibition of LDL oxidation.
• Metabolic / Endocrine system: Modulation of postprandial blood glucose and insulin response; potential reduction of type 2 diabetes risk.
• Gastrointestinal system: Prebiotic substrate activity promoting beneficial microbiota diversity and short-chain fatty acid production.
• Body composition: Reduction of truncal and total fat mass when incorporated into energy-controlled diets.
• Antioxidant / Inflammatory pathways: Reduction of oxidative stress markers; preliminary anti-inflammatory effects largely established in preclinical models.
• Neurological / Cognitive: Preliminary signals in RCT data; no established clinical indication.
• Integumentary system (skin): Preliminary RCT data for UV-related skin aging; mechanistic plausibility via vitamin E and fatty acid content.

Dosage Forms and Dosages Reported in Studies

Trials of almond dietary supplementation in adults have used 25 to 168 g of almonds per day. The American Heart Association (AHA) recommends the daily intake of nuts (28.35 to 56.7 g) as part of a healthy diet.

The following specific doses have been documented in the clinical literature:

• An intake of 42.5 g/day of almonds has been reported to significantly lower LDL cholesterol, 10-year Framingham estimated coronary heart disease risk, and associated cardiovascular disease medical expenditures.
• Diastolic blood pressure was modestly but significantly lowered when almonds were consumed at greater than 42.5 g/day or for greater than 6 weeks.
• A single premeal almond load of 20 g (given 30 minutes before meals) was evaluated for postprandial glycemic effects in a crossover randomized controlled study (n = 60).
• In a 90-day RCT in adolescents and young adults with impaired glucose levels, participants consumed 56 g of almonds daily.
• The global consensus on almond consumption notes that doses ranging from 10 to 100 g/day for periods up to 18 months do not lead to weight gain and may contribute to slight weight loss.
• In a cognitive performance trial, groups consuming 42 g/day and 84 g/day of almonds were evaluated over 3 and 6 months, respectively.

Almonds are consumed as whole kernels, almond butter, almond flour, almond oil, or almond milk. Consumption of sweet almond has Generally Recognized as Safe (GRAS) status in the United States when used as food.

Safety Considerations and Notable Precautions

Sweet Almond: General Safety

Consumption of sweet almond has GRAS status when used as food. Doses above those found in food should be approached with caution as safety at pharmacological quantities has not been established through formal toxicological programs. Almonds are the least allergenic tree nut and contain only minute quantities of cyanogenic glycosides.

Bitter Almond: Cyanogenic Toxicity

The safety profile of bitter almond is fundamentally different from that of the sweet variety. The toxicity of bitter almonds is caused by the accumulation of the cyanogenic diglucoside amygdalin, which releases toxic hydrogen cyanide upon hydrolysis.

The acute oral lethal dose of hydrogen cyanide (HCN) for humans is reported to be 0.5–3.5 mg/kg of body weight, and the consumption of 50 bitter almonds is considered deadly for adults. For young children, 5–10 bitter almonds are potentially fatal.

Despite numerous contributions on cancer cell lines, the clinical evidence for the anticancer activity of amygdalin is not fully confirmed. Moreover, high-dose exposures to amygdalin can produce cyanide toxicity.

Adverse reactions similar to those of cyanide poisoning have been reported. Cyanide poisoning and death have resulted from laetrile and bitter almond consumption.

Consumption of bitter almond or laetrile is not recommended in pregnant or breastfeeding women because of insufficient data and a theoretical risk of birth defects.

Amygdalin / Laetrile

Amygdalin is hydrolyzed to yield glucose, benzaldehyde, and hydrocyanic acid. The production of cyanide defines cyanogenic glycosides. Enzymatic release of cyanide can occur in the presence of beta-glucuronidase, an enzyme found in the seeds and in the human intestine. The term "laetrile" is often used interchangeably with amygdalin, but they are not the same chemical entity. The word was coined from "laevorotatory" and "mandelonitrile" and describes a semisynthetic derivative of amygdalin. There is no widely accepted standard for laetrile/amygdalin dosing due to the potential for toxicity and no evidence for efficacy.

Allergy

Tree nut allergy, including allergy to almonds, is a recognized clinical entity. Allergy to almonds or their products represents a formal contraindication to use. However, as noted above, almonds are considered the least allergenic of the major tree nuts, with IgE-mediated reactions being less common than with, for instance, cashew or walnut.

Drug Interactions

No well-documented pharmacokinetic or pharmacodynamic drug interactions with sweet almond have been established in the published literature. The high fat content of almonds may theoretically affect the absorption kinetics of fat-soluble drugs, and the fiber content may modestly delay gastric emptying, but these effects have not been characterized in formal interaction studies.

References

• Moronfolu IA et al. Prunus amygdalus Batsch (Almond): A Comprehensive Review of Botanical Classification, Ethnomedicinal Applications, Nutritional Composition, Phytochemical Profile, and Therapeutic Potential. ScienceDirect, 2026.
• Barreca D et al. Almonds (Prunus Dulcis Mill. D.A. Webb): A Source of Nutrients and Health-Promoting Compounds. PMC / Nutrients, 2020.
• Chin SK et al. The Almond (Prunus dulcis): Chemical Properties, Utilization, and Valorization of Coproducts. PubMed, 2022.
• Lee-Bravatti MA et al. Almond Consumption and Risk Factors for Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. PubMed / Advances in Nutrition, 2019.
• Dikariyanto V et al. Snacking on Whole Almonds for 6 Weeks Improves Endothelial Function and Lowers LDL Cholesterol but Does Not Affect Liver Fat and Other Cardiometabolic Risk Factors in Healthy Adults: the ATTIS Study, a Randomized Controlled Trial. PMC, 2020.
• Liu Z et al. Almonds Ameliorate Glycemic Control in Chinese Patients with Better Controlled Type 2 Diabetes: A Randomized, Crossover, Controlled Feeding Trial. PMC, 2017.
• Gulati S et al. Beneficial Effects of Premeal Almond Load on Glucose Profile on Oral Glucose Tolerance and Continuous Glucose Monitoring: Randomized Crossover Trials in Asian Indians with Prediabetes. PMC, 2023.
• Josse AR et al. Acute and Second-Meal Effects of Almond Form in Impaired Glucose Tolerant Adults: A Randomized Crossover Trial. PMC, 2011.
• Gulati S et al. Effect of Almond Consumption on Metabolic Risk Factors — Glucose Metabolism, Hyperinsulinemia, Selected Markers of Inflammation: A Randomized Controlled Trial in Adolescents and Young Adults. PMC, 2021.
• Dreher ML. A Comprehensive Review of Almond Clinical Trials on Weight Measures, Metabolic Health Biomarkers and Outcomes, and the Gut Microbiota. PMC / Nutrients, 2021.
• Alsubhi A et al. The Effects of Almond Consumption on Cardiovascular Health and Gut Microbiome: A Comprehensive Review. PMC, 2024.
• Dhaliwal J et al. Almond Snacking for 8 Weeks Increases Alpha-Diversity of the Gastrointestinal Microbiome and Decreases Bacteroides fragilis Abundance Compared with an Isocaloric Snack in College Freshmen. PMC, 2019.
• Bolling BW et al. Quantification of Almond Skin Polyphenols by Liquid Chromatography-Mass Spectrometry. PMC / Journal of Food Science, 2014.
• Foolad N et al. Prospective Randomized Controlled Pilot Study on the Effects of Almond Consumption on Skin Lipids and Wrinkles. PMC, 2019.
• Bolarinwa IF et al. Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds. PMC, 2021.
• Sánchez-Pérez R et al. Elucidation of the Amygdalin Pathway Reveals the Metabolic Basis of Bitter and Sweet Almonds (Prunus dulcis). PMC, 2018.
• Hassanpour Fard M et al. Potential Toxic Levels of Cyanide in Almonds (Prunus amygdalus), Apricot Kernels (Prunus armeniaca), and Almond Syrup. PMC, 2013.
• Lazzara V et al. Antioxidant Activity of a Sicilian Almond Skin Extract Using In Vitro and In Vivo Models. PMC, 2023.
• Chen CY et al. In Vitro Activity of Almond Skin Polyphenols for Scavenging Free Radicals and Inducing Quinone Reductase. PubMed / Journal of Agricultural and Food Chemistry, 2008.
• Coates AM et al. Effect of a 12-Week Almond-Enriched Diet on Biomarkers of Cognitive Performance, Mood, and Cardiometabolic Health in Older Overweight Adults. PMC, 2020.
• Drugs.com Natural Products Database: Almond / Almond Oil — Uses, Benefits & Dosage.
• Examining the Potential Prebiotic Effect of Almonds. Journal of Applied Microbiology, 2025.